Virtu KCG Holdings’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$424K Sell
21,899
-15,667
-42% -$273K 0.01% 1300
2017
Q1
$665K Sell
37,566
-5,908
-14% -$110K 0.02% 1076
2016
Q4
$645K Sell
43,474
-6,818
-14% -$122K 0.02% 1220
2016
Q3
$1.14M Buy
50,292
+32,486
+182% +$846K 0.03% 610
2016
Q2
$492K Buy
17,806
+624
+4% +$18.4K 0.01% 1377
2016
Q1
$497K Sell
17,182
-9,029
-34% -$235K 0.01% 1202
2015
Q4
$794K Buy
26,211
+20,643
+371% +$677K 0.01% 1059
2015
Q3
$206K Buy
+5,568
New +$288K ﹤0.01% 2545
2015
Q2
Sell
-23,947
Closed -$1.19M 3750
2015
Q1
$1.19M Buy
23,947
+5,811
+32% +$272K 0.02% 657
2014
Q4
$919K Buy
18,136
+9,408
+108% +$492K 0.02% 1023
2014
Q3
$518K Sell
8,728
-3,918
-31% -$219K 0.01% 1655
2014
Q2
$594K Buy
+12,646
New +$571K 0.01% 1756
2013
Q4
Sell
-23,407
Closed -$964K 4254
2013
Q3
$964K Buy
+23,407
New +$979K 0.01% 1202

Other funds holding THC

Virtu KCG Holdings's THC Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Tenet Healthcare (THC) stake by 42% in Q2 2017, selling an estimated $273K and leaving 21,899 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #1300.

Virtu KCG Holdings first reported a position in THC in Q3 2013 and has held it in 13 quarters since. The position peaked at $1.19M in Q1 2015. 246 funds tracked by Wall St. Rank hold THC as of Q2 2017.

  • Virtu KCG Holdings held 21,899 shares of Tenet Healthcare worth $424K as of Q2 2017.
  • Virtu KCG Holdings sold 15,667 Tenet Healthcare shares in Q2 2017, an estimated $273K.
  • Tenet Healthcare made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1300 holding.
  • Virtu KCG Holdings first reported a position in Tenet Healthcare in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Tenet Healthcare position peaked at $1.19M in Q1 2015.
  • 246 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.